Trinity Biotech (TRIB) Other Non-Current Assets (2009 - 2025)

Trinity Biotech has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $28000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $28000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $28000.0 (changed 0.0% YoY), and the FY2025 annual result was $28000.0, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $28000.0 for Q4 2025 at Trinity Biotech, roughly flat from $28000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $315000.0 in Q1 2021 to a low of $28000.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $114000.0 (2023), against an average of $133944.4.
• Across the five-year window, Other Non-Current Assets slumped 64.56% in 2024 and changed 0.0% in 2025, its largest moves.
• Trinity Biotech's Other Non-Current Assets stood at $207000.0 in 2021, then tumbled by 32.85% to $139000.0 in 2022, then sank by 43.17% to $79000.0 in 2023, then plunged by 64.56% to $28000.0 in 2024, then changed by 0.0% to $28000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $28000.0 (Q4 2025), $28000.0 (Q2 2025), and $28000.0 (Q4 2024), per Business Quant data.